Home > Financial Ratios > INDOCO REMEDIES

INDOCO REMEDIES
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 13.0117.1421.1717.5910.92

What is the latest Core EBITDA Margin ratio of INDOCO REMEDIES ?

The latest Core EBITDA Margin ratio of INDOCO REMEDIES is 13.01 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202413.01
Mar202317.14
Mar202221.17
Mar202117.59
Mar202010.92

How is Core EBITDA Margin of INDOCO REMEDIES Trending?

Years Core EBITDA Margin % Change
Mar2024 13.01
-24.10
Mar2023 17.14
-19.04
Mar2022 21.17
20.35
Mar2021 17.59
61.08
Mar2020 10.92 -

Other Financial Ratios of INDOCO REMEDIES


Compare Core EBITDA Margin ratio of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹3,100.2 Cr 2.1% 4.3% -13.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹443,661.0 Cr -1.8% 2.7% 49.1% Stock Analytics
DIVIS LABORATORIES ₹160,496.0 Cr -0.2% -3.4% 57% Stock Analytics
CIPLA ₹121,970.0 Cr -0.7% 0.6% 22.9% Stock Analytics
DR REDDYS LABORATORIES ₹112,877.0 Cr -1.8% 11.3% 18% Stock Analytics
ZYDUS LIFESCIENCES ₹98,163.2 Cr 1.9% 0.5% 41.9% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

2.1%

4.3%

-13.4%

SENSEX

0.7%

-2%

9.7%


You may also like the below Video Courses